Bonnie Spira

1.1k total citations
17 papers, 915 citations indexed

About

Bonnie Spira is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Bonnie Spira has authored 17 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 12 papers in Virology and 6 papers in Immunology. Recurrent topics in Bonnie Spira's work include HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (4 papers). Bonnie Spira is often cited by papers focused on HIV Research and Treatment (12 papers), HIV/AIDS drug development and treatment (12 papers) and HIV/AIDS Research and Interventions (4 papers). Bonnie Spira collaborates with scholars based in Canada and United States. Bonnie Spira's co-authors include Mark A. Wainberg, Bluma Brenner, Jean‐Pierre Routy, Brian Conway, Daniela Moïsi, Maureen Oliveira, Mervi Detorio, Qing Gao, Hugo Soudeyns and Xiaojian Yao and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Bonnie Spira

17 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bonnie Spira Canada	11	790	718	178	117	57	17	915
Christian Tourrès France	15	556 0.7×	604 0.8×	160 0.9×	92 0.8×	69 1.2×	25	742
Jingyun Li China	18	724 0.9×	814 1.1×	301 1.7×	79 0.7×	176 3.1×	90	1.1k
María Teresa Cuevas Spain	19	574 0.7×	600 0.8×	353 2.0×	142 1.2×	76 1.3×	44	898
L Heyndrickx Belgium	13	475 0.6×	554 0.8×	138 0.8×	100 0.9×	63 1.1×	16	648
Roberta D’Arrigo Italy	20	717 0.9×	735 1.0×	160 0.9×	261 2.2×	75 1.3×	37	957
Kirsi Liitsola Finland	14	490 0.6×	490 0.7×	283 1.6×	55 0.5×	50 0.9×	39	702
M. B. Vasudevachari United States	12	550 0.7×	693 1.0×	196 1.1×	126 1.1×	140 2.5×	21	861
Dana N. Raugi United States	15	415 0.5×	395 0.6×	131 0.7×	109 0.9×	59 1.0×	26	578
Claire Mulanga-Kabeya France	9	529 0.7×	548 0.8×	224 1.3×	71 0.6×	25 0.4×	11	727
Richard T. D'Aquila United States	7	867 1.1×	829 1.2×	118 0.7×	56 0.5×	21 0.4×	8	929

Countries citing papers authored by Bonnie Spira

Since Specialization

Citations

This map shows the geographic impact of Bonnie Spira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bonnie Spira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bonnie Spira more than expected).

Fields of papers citing papers by Bonnie Spira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bonnie Spira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bonnie Spira. The network helps show where Bonnie Spira may publish in the future.

Co-authorship network of co-authors of Bonnie Spira

This figure shows the co-authorship network connecting the top 25 collaborators of Bonnie Spira. A scholar is included among the top collaborators of Bonnie Spira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bonnie Spira. Bonnie Spira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Oliveira, Maureen, Daniela Moïsi, Bonnie Spira, et al.. (2009). Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations. Antimicrobial Agents and Chemotherapy. 53(4). 1683–1685. 8 indexed citations

Loemba, Hugues, Bluma Brenner, Michael A. Parniak, et al.. (2002). Polymorphisms of cytotoxic T-lymphocyte (CTL) and T-helper epitopes within reverse transcriptase (RT) of HIV-1 subtype C from Ethiopia and Botswana following selection of antiretroviral drug resistance. Antiviral Research. 56(2). 129–142. 22 indexed citations

Loemba, Hugues, Bluma Brenner, Michael A. Parniak, et al.. (2002). Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT. Antimicrobial Agents and Chemotherapy. 46(7). 2087–2094. 102 indexed citations

Loemba, Hugues, Bluma Brenner, Michael A. Parniak, et al.. (2002). Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana.. PubMed. 7(2). 141–8. 10 indexed citations

Brenner, Bluma, Jean‐Pierre Routy, Marco Petrella, et al.. (2002). Persistence and Fitness of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Acquired in Primary Infection. Journal of Virology. 76(4). 1753–1761. 177 indexed citations

Brenner, Bluma, Mark A. Wainberg, Horacio Salomón, et al.. (2000). Resistance to antiretroviral drugs in patients with primary HIV-1 infection. International Journal of Antimicrobial Agents. 16(4). 429–434. 53 indexed citations

Salomón, Horacio, Mark A. Wainberg, Bluma Brenner, et al.. (2000). Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. AIDS. 14(2). F17–F23. 180 indexed citations

Lewis, Linda, Horacio Salomón, N. Cammack, et al.. (1996). Resistance to (-)-2',3'-dideoxy-3'-thiacytidine (3TC) in HIV-1 isolated from paediatric patients.. PubMed. 1(2). 98–104. 6 indexed citations

Montaner, Julio, Joel Singer, Martin T. Schechter, et al.. (1993). Clinical correlates of in vitro HIV-1 resistance to zidovudine. Results of the Multicentre Canadian AZT Trial. AIDS. 7(2). 189–196. 62 indexed citations

10.

Wainberg, Mark A., et al.. (1993). HIV resistance to anti-viral drugs.. PubMed. 26(3). 299–308. 1 indexed citations

11.

Soudeyns, Hugo, Xiaojian Yao, Qing Gao, et al.. (1991). Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. Antimicrobial Agents and Chemotherapy. 35(7). 1386–1390. 197 indexed citations

12.

Wainberg, Mark A., Bonnie Spira, G. Bleau, & Rose V. Thomas. (1990). Inactivation of human immunodeficiency virus type 1 in tissue culture fluid and in genital secretions by the spermicide benzalkonium chloride. Journal of Clinical Microbiology. 28(1). 156–158. 32 indexed citations

13.

Numazaki, Kei, et al.. (1989). Infection of cultured human thymic epithelial cells by human immunodeficiency virus. Clinical Immunology and Immunopathology. 51(2). 185–195. 21 indexed citations

14.

Numazaki, Kei, et al.. (1989). Replication of cytomegalovirus in human thymic epithelial cells. Medical Microbiology and Immunology. 178(2). 89–98. 10 indexed citations

15.

Spira, Bonnie, et al.. (1987). Inhibition of human lymphocyte mitogenesis by human and other retroviruses. Differential effect of interleukin-2 in restoration of responsiveness.. PubMed. 1(2). 83–7. 8 indexed citations

16.

Wainberg, M A, et al.. (1985). Inhibition by human T-lymphotropic virus (HTLV-I) of T-lymphocyte mitogenesis: failure of exogenous T-cell growth factor to restore responsiveness to lectin.. PubMed. 54(1). 1–7. 18 indexed citations

17.

Wainberg, M A, et al.. (1984). Reversible interference with TCGF activity by virus particles.. PubMed. 57(3). 663–70. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact